EKF Diagnostics Holdings plc
EKF Diagnostics Holdings plc EKDHF Peers
See (EKDHF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EKDHF | $0.36 | +1.15% | 161.7M | 18.00 | $0.02 | N/A |
| SEMHF | $55.30 | +0.36% | 62B | 26.08 | $2.12 | +2.03% |
| SMMNY | $26.42 | -1.01% | 59.3B | 24.92 | $1.06 | +0.99% |
| RYLPF | $23.23 | -0.04% | 21.5B | 80.09 | $0.29 | +4.09% |
| SONVY | $62.72 | +0.17% | 18.7B | 28.64 | $2.19 | +1.52% |
| SONVF | $311.34 | -1.27% | 18.6B | 28.48 | $10.93 | +1.88% |
| SNNUF | $14.30 | N/A | 12.5B | 30.43 | $0.47 | +2.62% |
| CHEOY | $87.26 | +0.79% | 11.4B | 47.68 | $1.83 | +1.62% |
| CHEOF | $170.00 | +1.19% | 11.1B | 46.70 | $3.64 | +1.63% |
| WILYY | $19.25 | N/A | 8.2B | 19.06 | $1.01 | N/A |
Stock Comparison
EKDHF vs SEMHF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SEMHF has a market cap of 62B. Regarding current trading prices, EKDHF is priced at $0.36, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SEMHF's P/E ratio is 26.08. In terms of profitability, EKDHF's ROE is +0.09%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, EKDHF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SMMNY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SMMNY has a market cap of 59.3B. Regarding current trading prices, EKDHF is priced at $0.36, while SMMNY trades at $26.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SMMNY's P/E ratio is 24.92. In terms of profitability, EKDHF's ROE is +0.09%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, EKDHF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs RYLPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, RYLPF has a market cap of 21.5B. Regarding current trading prices, EKDHF is priced at $0.36, while RYLPF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas RYLPF's P/E ratio is 80.09. In terms of profitability, EKDHF's ROE is +0.09%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, EKDHF is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SONVY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SONVY has a market cap of 18.7B. Regarding current trading prices, EKDHF is priced at $0.36, while SONVY trades at $62.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SONVY's P/E ratio is 28.64. In terms of profitability, EKDHF's ROE is +0.09%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, EKDHF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SONVF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SONVF has a market cap of 18.6B. Regarding current trading prices, EKDHF is priced at $0.36, while SONVF trades at $311.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SONVF's P/E ratio is 28.48. In terms of profitability, EKDHF's ROE is +0.09%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, EKDHF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SNNUF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SNNUF has a market cap of 12.5B. Regarding current trading prices, EKDHF is priced at $0.36, while SNNUF trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SNNUF's P/E ratio is 30.43. In terms of profitability, EKDHF's ROE is +0.09%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, EKDHF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CHEOY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CHEOY has a market cap of 11.4B. Regarding current trading prices, EKDHF is priced at $0.36, while CHEOY trades at $87.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CHEOY's P/E ratio is 47.68. In terms of profitability, EKDHF's ROE is +0.09%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, EKDHF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CHEOF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CHEOF has a market cap of 11.1B. Regarding current trading prices, EKDHF is priced at $0.36, while CHEOF trades at $170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CHEOF's P/E ratio is 46.70. In terms of profitability, EKDHF's ROE is +0.09%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, EKDHF is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs WILYY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, WILYY has a market cap of 8.2B. Regarding current trading prices, EKDHF is priced at $0.36, while WILYY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas WILYY's P/E ratio is 19.06. In terms of profitability, EKDHF's ROE is +0.09%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, EKDHF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs WILLF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, WILLF has a market cap of 7.5B. Regarding current trading prices, EKDHF is priced at $0.36, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas WILLF's P/E ratio is 17.95. In terms of profitability, EKDHF's ROE is +0.09%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, EKDHF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs NGMDF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, NGMDF has a market cap of 5.4B. Regarding current trading prices, EKDHF is priced at $0.36, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas NGMDF's P/E ratio is -5.97. In terms of profitability, EKDHF's ROE is +0.09%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, EKDHF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs GNGBY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, GNGBY has a market cap of 5.3B. Regarding current trading prices, EKDHF is priced at $0.36, while GNGBY trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas GNGBY's P/E ratio is 33.77. In terms of profitability, EKDHF's ROE is +0.09%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, EKDHF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs GNGBF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, GNGBF has a market cap of 5.1B. Regarding current trading prices, EKDHF is priced at $0.36, while GNGBF trades at $20.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas GNGBF's P/E ratio is 35.47. In terms of profitability, EKDHF's ROE is +0.09%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, EKDHF is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs AMBFF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, AMBFF has a market cap of 5.1B. Regarding current trading prices, EKDHF is priced at $0.36, while AMBFF trades at $19.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas AMBFF's P/E ratio is 91.43. In terms of profitability, EKDHF's ROE is +0.09%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, EKDHF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs AMBBY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, AMBBY has a market cap of 4.1B. Regarding current trading prices, EKDHF is priced at $0.36, while AMBBY trades at $15.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas AMBBY's P/E ratio is 75.10. In terms of profitability, EKDHF's ROE is +0.09%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, EKDHF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs NHNKY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, NHNKY has a market cap of 3.9B. Regarding current trading prices, EKDHF is priced at $0.36, while NHNKY trades at $12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas NHNKY's P/E ratio is 20.10. In terms of profitability, EKDHF's ROE is +0.09%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, EKDHF is more volatile compared to NHNKY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs NHNKF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, EKDHF is priced at $0.36, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, EKDHF's ROE is +0.09%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, EKDHF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs VTRLY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, VTRLY has a market cap of 2.2B. Regarding current trading prices, EKDHF is priced at $0.36, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas VTRLY's P/E ratio is 42.03. In terms of profitability, EKDHF's ROE is +0.09%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, EKDHF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs OSSFF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, OSSFF has a market cap of 2.2B. Regarding current trading prices, EKDHF is priced at $0.36, while OSSFF trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas OSSFF's P/E ratio is 30.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, EKDHF is more volatile compared to OSSFF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs GNNDY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, EKDHF is priced at $0.36, while GNNDY trades at $44.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas GNNDY's P/E ratio is 17.47. In terms of profitability, EKDHF's ROE is +0.09%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, EKDHF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs STSEY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, EKDHF is priced at $0.36, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas STSEY's P/E ratio is 39.41. In terms of profitability, EKDHF's ROE is +0.09%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, EKDHF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs GGNDF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, GGNDF has a market cap of 1.8B. Regarding current trading prices, EKDHF is priced at $0.36, while GGNDF trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas GGNDF's P/E ratio is 14.60. In terms of profitability, EKDHF's ROE is +0.09%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, EKDHF is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DWRKF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, EKDHF is priced at $0.36, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, EKDHF's ROE is +0.09%, compared to DWRKF's ROE of N/A. Regarding short-term risk, EKDHF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MCRPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MCRPF has a market cap of 1.7B. Regarding current trading prices, EKDHF is priced at $0.36, while MCRPF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MCRPF's P/E ratio is -7.85. In terms of profitability, EKDHF's ROE is +0.09%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, EKDHF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs OSSUY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, EKDHF is priced at $0.36, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, EKDHF's ROE is +0.09%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, EKDHF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MEDGF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, EKDHF is priced at $0.36, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, EKDHF's ROE is +0.09%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, EKDHF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DRWKF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DRWKF has a market cap of 1.3B. Regarding current trading prices, EKDHF is priced at $0.36, while DRWKF trades at $70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DRWKF's P/E ratio is 9.30. In terms of profitability, EKDHF's ROE is +0.09%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, EKDHF is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs IMEXF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, IMEXF has a market cap of 1.2B. Regarding current trading prices, EKDHF is priced at $0.36, while IMEXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, EKDHF's ROE is +0.09%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, EKDHF is more volatile compared to IMEXF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DGWPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, EKDHF is priced at $0.36, while DGWPF trades at $55.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DGWPF's P/E ratio is 7.44. In terms of profitability, EKDHF's ROE is +0.09%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, EKDHF is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs XVIPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, EKDHF is priced at $0.36, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, EKDHF's ROE is +0.09%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, EKDHF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs LFTSF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, LFTSF has a market cap of 858.1M. Regarding current trading prices, EKDHF is priced at $0.36, while LFTSF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas LFTSF's P/E ratio is 19.50. In terms of profitability, EKDHF's ROE is +0.09%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, EKDHF is less volatile compared to LFTSF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ELEAF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ELEAF has a market cap of 759.8M. Regarding current trading prices, EKDHF is priced at $0.36, while ELEAF trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ELEAF's P/E ratio is 11.02. In terms of profitability, EKDHF's ROE is +0.09%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, EKDHF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MDRSF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MDRSF has a market cap of 638.4M. Regarding current trading prices, EKDHF is priced at $0.36, while MDRSF trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MDRSF's P/E ratio is 151.47. In terms of profitability, EKDHF's ROE is +0.09%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, EKDHF is more volatile compared to MDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CALZF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CALZF has a market cap of 559.2M. Regarding current trading prices, EKDHF is priced at $0.36, while CALZF trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CALZF's P/E ratio is 80.95. In terms of profitability, EKDHF's ROE is +0.09%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, EKDHF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CLVSF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CLVSF has a market cap of 556.5M. Regarding current trading prices, EKDHF is priced at $0.36, while CLVSF trades at $23.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CLVSF's P/E ratio is 38.25. In terms of profitability, EKDHF's ROE is +0.09%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, EKDHF is more volatile compared to CLVSF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs LBLTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, LBLTF has a market cap of 496.1M. Regarding current trading prices, EKDHF is priced at $0.36, while LBLTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas LBLTF's P/E ratio is -1.22. In terms of profitability, EKDHF's ROE is +0.09%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, EKDHF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs AVMR Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, EKDHF is priced at $0.36, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas AVMR's P/E ratio is -18.34. In terms of profitability, EKDHF's ROE is +0.09%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, EKDHF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs IOBCF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, IOBCF has a market cap of 404.3M. Regarding current trading prices, EKDHF is priced at $0.36, while IOBCF trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas IOBCF's P/E ratio is 38.33. In terms of profitability, EKDHF's ROE is +0.09%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, EKDHF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs HYBT Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, EKDHF is priced at $0.36, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas HYBT's P/E ratio is N/A. In terms of profitability, EKDHF's ROE is +0.09%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, EKDHF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs EAPIF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, EAPIF has a market cap of 290.4M. Regarding current trading prices, EKDHF is priced at $0.36, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, EKDHF's ROE is +0.09%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, EKDHF is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DMTRF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DMTRF has a market cap of 276.8M. Regarding current trading prices, EKDHF is priced at $0.36, while DMTRF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DMTRF's P/E ratio is -35.86. In terms of profitability, EKDHF's ROE is +0.09%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, EKDHF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CSSPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CSSPF has a market cap of 263.4M. Regarding current trading prices, EKDHF is priced at $0.36, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, EKDHF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CLLKF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CLLKF has a market cap of 255.6M. Regarding current trading prices, EKDHF is priced at $0.36, while CLLKF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CLLKF's P/E ratio is -8.04. In terms of profitability, EKDHF's ROE is +0.09%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, EKDHF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs HTLZF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, EKDHF is priced at $0.36, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, EKDHF's ROE is +0.09%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, EKDHF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CYBQY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CYBQY has a market cap of 209.9M. Regarding current trading prices, EKDHF is priced at $0.36, while CYBQY trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CYBQY's P/E ratio is -50.50. In terms of profitability, EKDHF's ROE is +0.09%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, EKDHF is more volatile compared to CYBQY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CYBQF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CYBQF has a market cap of 173.5M. Regarding current trading prices, EKDHF is priced at $0.36, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, EKDHF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs BCCOY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, BCCOY has a market cap of 172.6M. Regarding current trading prices, EKDHF is priced at $0.36, while BCCOY trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas BCCOY's P/E ratio is -5.68. In terms of profitability, EKDHF's ROE is +0.09%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, EKDHF is more volatile compared to BCCOY. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs AVHHL Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, AVHHL has a market cap of 164.2M. Regarding current trading prices, EKDHF is priced at $0.36, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, EKDHF's ROE is +0.09%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, EKDHF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs BRNHF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, BRNHF has a market cap of 161.8M. Regarding current trading prices, EKDHF is priced at $0.36, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, EKDHF's ROE is +0.09%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, EKDHF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs JMDMF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, JMDMF has a market cap of 152M. Regarding current trading prices, EKDHF is priced at $0.36, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, EKDHF's ROE is +0.09%, compared to JMDMF's ROE of N/A. Regarding short-term risk, EKDHF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs BRSYF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, BRSYF has a market cap of 128.4M. Regarding current trading prices, EKDHF is priced at $0.36, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, EKDHF's ROE is +0.09%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, EKDHF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs VMTHF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, VMTHF has a market cap of 125.7M. Regarding current trading prices, EKDHF is priced at $0.36, while VMTHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas VMTHF's P/E ratio is -1.25. In terms of profitability, EKDHF's ROE is +0.09%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, EKDHF is more volatile compared to VMTHF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs AMEUF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, EKDHF is priced at $0.36, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, EKDHF's ROE is +0.09%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, EKDHF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs PXMBF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, PXMBF has a market cap of 114.4M. Regarding current trading prices, EKDHF is priced at $0.36, while PXMBF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas PXMBF's P/E ratio is 23.33. In terms of profitability, EKDHF's ROE is +0.09%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, EKDHF is less volatile compared to PXMBF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs FDMDF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, EKDHF is priced at $0.36, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, EKDHF's ROE is +0.09%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, EKDHF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs IMPZY Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, IMPZY has a market cap of 100M. Regarding current trading prices, EKDHF is priced at $0.36, while IMPZY trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas IMPZY's P/E ratio is -0.80. In terms of profitability, EKDHF's ROE is +0.09%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, EKDHF is less volatile compared to IMPZY. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs TCLIF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, TCLIF has a market cap of 96.4M. Regarding current trading prices, EKDHF is priced at $0.36, while TCLIF trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas TCLIF's P/E ratio is -23.11. In terms of profitability, EKDHF's ROE is +0.09%, compared to TCLIF's ROE of -0.74%. Regarding short-term risk, EKDHF is less volatile compared to TCLIF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs RSHUF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, EKDHF is priced at $0.36, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, EKDHF's ROE is +0.09%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, EKDHF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CKMTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, EKDHF is priced at $0.36, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, EKDHF's ROE is +0.09%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, EKDHF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SOMNF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SOMNF has a market cap of 79.4M. Regarding current trading prices, EKDHF is priced at $0.36, while SOMNF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SOMNF's P/E ratio is -12.25. In terms of profitability, EKDHF's ROE is +0.09%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, EKDHF is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs SNZZF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, SNZZF has a market cap of 73.2M. Regarding current trading prices, EKDHF is priced at $0.36, while SNZZF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas SNZZF's P/E ratio is -5.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, EKDHF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs RDGL Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, RDGL has a market cap of 59M. Regarding current trading prices, EKDHF is priced at $0.36, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas RDGL's P/E ratio is -13.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, EKDHF is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs BLOZF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, BLOZF has a market cap of 49.6M. Regarding current trading prices, EKDHF is priced at $0.36, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas BLOZF's P/E ratio is -21.53. In terms of profitability, EKDHF's ROE is +0.09%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, EKDHF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs CRRVF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, CRRVF has a market cap of 46.3M. Regarding current trading prices, EKDHF is priced at $0.36, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, EKDHF's ROE is +0.09%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, EKDHF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs IPDQF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, IPDQF has a market cap of 40.5M. Regarding current trading prices, EKDHF is priced at $0.36, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas IPDQF's P/E ratio is -2.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, EKDHF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs NVYTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, NVYTF has a market cap of 38.1M. Regarding current trading prices, EKDHF is priced at $0.36, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas NVYTF's P/E ratio is -0.73. In terms of profitability, EKDHF's ROE is +0.09%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, EKDHF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs TLTFF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, TLTFF has a market cap of 37.2M. Regarding current trading prices, EKDHF is priced at $0.36, while TLTFF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas TLTFF's P/E ratio is -15.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, EKDHF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ELXMF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, EKDHF is priced at $0.36, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, EKDHF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs PLLWF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, PLLWF has a market cap of 24.1M. Regarding current trading prices, EKDHF is priced at $0.36, while PLLWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas PLLWF's P/E ratio is -2.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, EKDHF is more volatile compared to PLLWF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs KBBTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, EKDHF is priced at $0.36, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, EKDHF's ROE is +0.09%, compared to KBBTF's ROE of N/A. Regarding short-term risk, EKDHF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs POSC Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, POSC has a market cap of 23.8M. Regarding current trading prices, EKDHF is priced at $0.36, while POSC trades at $1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas POSC's P/E ratio is 0.37. In terms of profitability, EKDHF's ROE is +0.09%, compared to POSC's ROE of +9.25%. Regarding short-term risk, EKDHF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs EMITF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, EMITF has a market cap of 22.2M. Regarding current trading prices, EKDHF is priced at $0.36, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas EMITF's P/E ratio is -14.29. In terms of profitability, EKDHF's ROE is +0.09%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, EKDHF is more volatile compared to EMITF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs PYNKF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, PYNKF has a market cap of 18.4M. Regarding current trading prices, EKDHF is priced at $0.36, while PYNKF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas PYNKF's P/E ratio is -0.94. In terms of profitability, EKDHF's ROE is +0.09%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, EKDHF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MDXHF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MDXHF has a market cap of 17.6M. Regarding current trading prices, EKDHF is priced at $0.36, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, EKDHF's ROE is +0.09%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, EKDHF is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ASAPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ASAPF has a market cap of 17.2M. Regarding current trading prices, EKDHF is priced at $0.36, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ASAPF's P/E ratio is -22.04. In terms of profitability, EKDHF's ROE is +0.09%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, EKDHF is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DIZTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DIZTF has a market cap of 16.1M. Regarding current trading prices, EKDHF is priced at $0.36, while DIZTF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DIZTF's P/E ratio is -10.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, EKDHF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs TMDIF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, EKDHF is priced at $0.36, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, EKDHF's ROE is +0.09%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, EKDHF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs VPTDF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, VPTDF has a market cap of 12.6M. Regarding current trading prices, EKDHF is priced at $0.36, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas VPTDF's P/E ratio is -3.84. In terms of profitability, EKDHF's ROE is +0.09%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, EKDHF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ZMSPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ZMSPF has a market cap of 12.3M. Regarding current trading prices, EKDHF is priced at $0.36, while ZMSPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ZMSPF's P/E ratio is N/A. In terms of profitability, EKDHF's ROE is +0.09%, compared to ZMSPF's ROE of +0.82%. Regarding short-term risk, EKDHF is less volatile compared to ZMSPF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ATBPF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, EKDHF is priced at $0.36, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, EKDHF's ROE is +0.09%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, EKDHF is more volatile compared to ATBPF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs LXXGF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, EKDHF is priced at $0.36, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, EKDHF's ROE is +0.09%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, EKDHF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs GTHP Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, GTHP has a market cap of 11M. Regarding current trading prices, EKDHF is priced at $0.36, while GTHP trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas GTHP's P/E ratio is -2.80. In terms of profitability, EKDHF's ROE is +0.09%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, EKDHF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs RMSL Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, RMSL has a market cap of 10.6M. Regarding current trading prices, EKDHF is priced at $0.36, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas RMSL's P/E ratio is 0.69. In terms of profitability, EKDHF's ROE is +0.09%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, EKDHF is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MKEAF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MKEAF has a market cap of 9.3M. Regarding current trading prices, EKDHF is priced at $0.36, while MKEAF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MKEAF's P/E ratio is -6.11. In terms of profitability, EKDHF's ROE is +0.09%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, EKDHF is less volatile compared to MKEAF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ALRTF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ALRTF has a market cap of 8M. Regarding current trading prices, EKDHF is priced at $0.36, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ALRTF's P/E ratio is -0.42. In terms of profitability, EKDHF's ROE is +0.09%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, EKDHF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs IRME Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, IRME has a market cap of 7.9M. Regarding current trading prices, EKDHF is priced at $0.36, while IRME trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas IRME's P/E ratio is -3.67. In terms of profitability, EKDHF's ROE is +0.09%, compared to IRME's ROE of +11.77%. Regarding short-term risk, EKDHF is more volatile compared to IRME. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs DTXMF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, DTXMF has a market cap of 5.7M. Regarding current trading prices, EKDHF is priced at $0.36, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, EKDHF's ROE is +0.09%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, EKDHF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs TBRIF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, TBRIF has a market cap of 5.7M. Regarding current trading prices, EKDHF is priced at $0.36, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas TBRIF's P/E ratio is -1.25. In terms of profitability, EKDHF's ROE is +0.09%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, EKDHF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs QLIS Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, EKDHF is priced at $0.36, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas QLIS's P/E ratio is 2.22. In terms of profitability, EKDHF's ROE is +0.09%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, EKDHF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs RHNMF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, EKDHF is priced at $0.36, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, EKDHF's ROE is +0.09%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, EKDHF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs NUMD Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, NUMD has a market cap of 5M. Regarding current trading prices, EKDHF is priced at $0.36, while NUMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas NUMD's P/E ratio is 6.00. In terms of profitability, EKDHF's ROE is +0.09%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, EKDHF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs MICR Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, EKDHF is priced at $0.36, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas MICR's P/E ratio is -3.47. In terms of profitability, EKDHF's ROE is +0.09%, compared to MICR's ROE of -0.25%. Regarding short-term risk, EKDHF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs FZMD Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, FZMD has a market cap of 4.6M. Regarding current trading prices, EKDHF is priced at $0.36, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas FZMD's P/E ratio is 1.24. In terms of profitability, EKDHF's ROE is +0.09%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, EKDHF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs VYCO Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, VYCO has a market cap of 3.9M. Regarding current trading prices, EKDHF is priced at $0.36, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas VYCO's P/E ratio is -11.79. In terms of profitability, EKDHF's ROE is +0.09%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, EKDHF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ADMT Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ADMT has a market cap of 3.8M. Regarding current trading prices, EKDHF is priced at $0.36, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ADMT's P/E ratio is -5.63. In terms of profitability, EKDHF's ROE is +0.09%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, EKDHF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs ESMC Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, ESMC has a market cap of 3.4M. Regarding current trading prices, EKDHF is priced at $0.36, while ESMC trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas ESMC's P/E ratio is 9.16. In terms of profitability, EKDHF's ROE is +0.09%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, EKDHF is more volatile compared to ESMC. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs VANIW Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, EKDHF is priced at $0.36, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas VANIW's P/E ratio is N/A. In terms of profitability, EKDHF's ROE is +0.09%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, EKDHF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs PMEDF Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, PMEDF has a market cap of 3.1M. Regarding current trading prices, EKDHF is priced at $0.36, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas PMEDF's P/E ratio is -2.03. In terms of profitability, EKDHF's ROE is +0.09%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, EKDHF is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.
EKDHF vs LLBO Comparison
EKDHF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EKDHF stands at 161.7M. In comparison, LLBO has a market cap of 3M. Regarding current trading prices, EKDHF is priced at $0.36, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EKDHF currently has a P/E ratio of 18.00, whereas LLBO's P/E ratio is N/A. In terms of profitability, EKDHF's ROE is +0.09%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, EKDHF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for EKDHF.